Skip to content
Menu

EFGCP Better Medicines for Children Conference 2026

Collaborating to Implement Innovative Approaches in Paediatric Development

The BMFC2026 Conference took place 29-30 September. This premier annual event provided a unique platform to share best practice, reflect on developments since our last meeting in October 2025, and explore paediatric updates and opportunities arising from European legislation, important scientific innovations, and paradigm shifts.

Development of paediatric medicines requires strong partnerships and collaboration between all relevant partners around the world, and we were delighted to welcome attendees to the conference. 

Key Details

  • Dates: 29-30 September 2026 (2 Days Duration)
  • Location: Amsterdam
  • Type: Hybrid Conference 
  • Language: English

The theme for 2026 was “Collaborating to Implement Innovative Approaches in Paediatric Development”.

This conference convened distinguished speakers from all around the world, relevant stakeholders and experts, to delve into the latest innovations in paediatrics. It addressed practical questions on how the revised European General Pharmaceutical Legislation and related initiatives, such as the EU Biotech Act, can be implemented to achieve the best possible outcomes for children living with health conditions and their families.

What did the programme cover?

Day One explored the evolving ethical and regulatory landscape in paediatric medicine development, alongside sessions on clinical research, innovation, and collaborative discussion through interactive breakout sessions. The day concluded with expert insights and networking opportunities.

Day Two focused on key takeaways from the breakout sessions, emerging innovations in paediatric drug development, and discussions on medical devices, global regulatory developments, and advances in rare diseases and cell and gene therapies.

  • Dates: 29-30 September 2026 (2 Days Duration)
  • Location: Amsterdam
  • Type: Hybrid Conference 
  • Language: English

The theme for 2026 was “Collaborating to Implement Innovative Approaches in Paediatric Development”.

This conference convened distinguished speakers from all around the world, relevant stakeholders and experts, to delve into the latest innovations in paediatrics. It addressed practical questions on how the revised European General Pharmaceutical Legislation and other initiatives such as the EU Biotech Act should be implemented to achieve the best outcomes for children living with health conditions and their families in the most effective manner. 

What will the programme cover?

Day One explored the evolving ethical and regulatory landscape in paediatric medicine development, alongside sessions on clinical research, innovation, and collaborative discussion through interactive breakout sessions. The day concluded with expert insights and networking opportunities.

Day Two focused on key takeaways from the breakout sessions, emerging innovations in paediatric drug development, and discussions on medical devices, global regulatory developments, and advances in rare diseases and cell and gene therapies.

Patronage



With the Support of


Gold


Bronze

 
Sanofi